Valeant to buy 'female Viagra' maker Sprout Pharma

(Reuters) – Canada’s Valeant Pharmaceuticals International Inc said on Thursday it would buy Sprout Pharmaceuticals, which makes a controversial new drug to treat low sexual desire in women, for about $1 billion.